Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | INSM | BIIB | ||
| Company | Horizon Therapeutics | Insmed Inc | Biogen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 116.34 | 163.00 | 169.03 | ||
| High | 116.38 | 164.00 | 169.79 | ||
| Low | 116.26 | 158.42 | 166.79 | ||
| Latest | 116.30 | 159.27 | 168.57 | ||
| Change | +0.05 | -4.19 | -0.74 | ||
| % Change | +0.04% | -2.56% | -0.44% | ||
| Volume | 28,881,200 | 2,314,200 | 1,562,700 | ||
| 20-Day Average Volume | 3,994,490 | 3,903,280 | 2,269,680 | ||
| Previous Close | 116.25 | 163.46 | 169.31 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 173.80 | 177.32 | ||
| 20-Day Raw Stochastic | 95.09% | 1.82% | 12.14% | ||
| 20-Day Relative Strength | 80.29 | 35.69 | 44.54 | ||
| Weighted Alpha | +49.30 | +89.19 | +25.46 | ||
| Today's Opinion | 88% Buy | 24% Buy | 56% Buy | ||
| Previous Opinion | 88% Buy | 24% Buy | 64% Buy | ||
| Last Month's Opinion | 40% Buy | 80% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | -6.46% since 01/08/26 | -9.37% since 01/08/26 | ||
| Low | 115.66 on 09/29/23 | 158.42 on 01/15/26 | 165.58 on 01/14/26 | ||
| High | 116.38 on 10/05/23 | 186.19 on 01/09/26 | 190.20 on 01/09/26 | ||
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | -19.12% since 12/15/25 | -4.08% since 12/15/25 | ||
| Low | 114.75 on 09/11/23 | 158.42 on 01/15/26 | 165.58 on 01/14/26 | ||
| High | 116.38 on 10/05/23 | 205.23 on 12/17/25 | 190.20 on 01/09/26 | ||
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | -2.61% since 10/15/25 | +17.34% since 10/15/25 | ||
| Low | 98.80 on 08/03/23 | 154.79 on 10/23/25 | 138.00 on 10/30/25 | ||
| High | 116.38 on 10/05/23 | 212.75 on 12/02/25 | 190.20 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | +54.83% since 07/15/25 | +32.21% since 07/15/25 | ||
| Low | 90.56 on 05/16/23 | 101.55 on 07/23/25 | 121.05 on 07/21/25 | ||
| High | 116.38 on 10/05/23 | 212.75 on 12/02/25 | 190.20 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 33,967,992 | 24,729,558 | ||
| Shares Outstanding, K | 228,995 | 213,273 | 146,702 | ||
| Annual Sales | 3,629,040,000 | 363,710,000 | 9,675,900,000 | ||
| Annual Net Income | 521,480,000 | -913,770,000 | 1,632,200,000 | ||
| Last Quarter Sales | 944,960,000 | 142,340,000 | 2,534,700,000 | ||
| Last Quarter Net Income | 127,070,000 | -370,020,000 | 466,500,000 | ||
| 60-Month Beta | 1.03 | 1.08 | 0.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | -1.75 on 10/30/25 | 4.81 on 10/30/25 | ||
| Latest Earnings Date | 11/01/23 | 02/19/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 0.00 | 10.11 | ||